Last reviewed · How we verify
placebo based quadriple therapy
A placebo-based quadruple therapy that relies on the placebo effect across four treatment components to produce therapeutic benefit.
At a glance
| Generic name | placebo based quadriple therapy |
|---|---|
| Also known as | Triple therapy (TT) |
| Sponsor | mohamed bouchoucha |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
This product is explicitly formulated as a placebo-based intervention, meaning it contains no active pharmaceutical ingredients. The therapeutic mechanism depends entirely on the placebo effect—the psychological and physiological response patients experience from the expectation of treatment. As a quadruple therapy, it combines four placebo components, potentially leveraging cumulative expectancy effects.
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- placebo based quadriple therapy CI brief — competitive landscape report
- placebo based quadriple therapy updates RSS · CI watch RSS
- mohamed bouchoucha portfolio CI